This month, there are the first clinical trial results from an intranasal DNA vaccine, with some signs that it might protect against…

A few months ago, I wrote about reasons to be concerned about the reliability of PubMed under the new regime at the…

This month, there’s good news about an intranasal vaccine in France that has a chance of making it over the line in…

Back in 2019 I wrote a couple of posts summarizing what we had learned from research about peer review at journals. Since…

This month, there are results from 3 clinical trials of next generation vaccines, including an early safety study of an intranasal vaccine…

The question keeps coming up when I discuss the challenges facing the Cochrane Collaboration: What’s happening with open access for Cochrane reviews?…

There are 2 pieces of exciting news from Europe this month. As anticipated, the European Commission has authorized Kostaive, the self-amplifying mRNA…

PubMed is incredibly reliable. And a lot depends on it. It’s an ecosystem built around MEDLINE, the steady feed of new publications…

This month, another intranasal vaccine has gone into clinical trial in Europe. It’s the 32nd mucosal vaccine to start clinical testing &ndash…

A process I’ve been involved with at a journal recently exploded. It was meant to resolve a controversy about a publication, not…

One of the critical ways a next generation Covid vaccine can improve on the original vaccines is to be more durable and…

The first next-generation Covid vaccine is on its way to authorization in the European Union. Recently rolled out in Japan, the self-amplifying…